FR2875404B1 - Composition pharmaceutique pour le traitement de la rosacee - Google Patents

Composition pharmaceutique pour le traitement de la rosacee

Info

Publication number
FR2875404B1
FR2875404B1 FR0409879A FR0409879A FR2875404B1 FR 2875404 B1 FR2875404 B1 FR 2875404B1 FR 0409879 A FR0409879 A FR 0409879A FR 0409879 A FR0409879 A FR 0409879A FR 2875404 B1 FR2875404 B1 FR 2875404B1
Authority
FR
France
Prior art keywords
rosacea
treatment
pharmaceutical composition
pharmaceutical
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0409879A
Other languages
English (en)
Other versions
FR2875404A1 (fr
Inventor
William Robert Pilgrim
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Galderma Research and Development SNC
Original Assignee
Galderma Research and Development SNC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galderma Research and Development SNC filed Critical Galderma Research and Development SNC
Priority to FR0409879A priority Critical patent/FR2875404B1/fr
Priority to EP05802503A priority patent/EP1791598A1/fr
Priority to CA002578121A priority patent/CA2578121A1/fr
Priority to JP2007531796A priority patent/JP2008513420A/ja
Priority to PCT/FR2005/002281 priority patent/WO2006032759A1/fr
Publication of FR2875404A1 publication Critical patent/FR2875404A1/fr
Priority to US11/723,378 priority patent/US20070219263A1/en
Application granted granted Critical
Publication of FR2875404B1 publication Critical patent/FR2875404B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR0409879A 2004-09-17 2004-09-17 Composition pharmaceutique pour le traitement de la rosacee Expired - Fee Related FR2875404B1 (fr)

Priority Applications (6)

Application Number Priority Date Filing Date Title
FR0409879A FR2875404B1 (fr) 2004-09-17 2004-09-17 Composition pharmaceutique pour le traitement de la rosacee
EP05802503A EP1791598A1 (fr) 2004-09-17 2005-09-14 Utilisation du metronidazole en combinaison avec de l'acide azelaique pour le traitement de la rosacee
CA002578121A CA2578121A1 (fr) 2004-09-17 2005-09-14 Utilisation du metronidazole en combinaison avec de l'acide azelaique pour le traitement de la rosacee
JP2007531796A JP2008513420A (ja) 2004-09-17 2005-09-14 アゼライン酸と組合せたメトロニダゾールのしゅさの処置のための使用
PCT/FR2005/002281 WO2006032759A1 (fr) 2004-09-17 2005-09-14 Utilisation du metronidazole en combinaison avec de l'acide azelaique pour le traitement de la rosacee
US11/723,378 US20070219263A1 (en) 2004-09-17 2007-03-19 Metronidazole/azelaic acid compositions for the treatment of rosacea

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0409879A FR2875404B1 (fr) 2004-09-17 2004-09-17 Composition pharmaceutique pour le traitement de la rosacee

Publications (2)

Publication Number Publication Date
FR2875404A1 FR2875404A1 (fr) 2006-03-24
FR2875404B1 true FR2875404B1 (fr) 2008-10-03

Family

ID=34951421

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0409879A Expired - Fee Related FR2875404B1 (fr) 2004-09-17 2004-09-17 Composition pharmaceutique pour le traitement de la rosacee

Country Status (6)

Country Link
US (1) US20070219263A1 (fr)
EP (1) EP1791598A1 (fr)
JP (1) JP2008513420A (fr)
CA (1) CA2578121A1 (fr)
FR (1) FR2875404B1 (fr)
WO (1) WO2006032759A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2316308B1 (es) * 2008-04-30 2010-02-15 Fundacion Universitaria San Pablo - Ceu Medicamento a base de metronidazol y acido azelaico para el tratamiento por via topica de la enfermedad rosacea de mejor asimilacion, y procedimiento de preparacion.
CA3158316A1 (fr) * 2019-10-16 2021-04-22 Curology, Inc. Compositions et methodes de traitement de l'acne et du photovieillissement
RU2741988C1 (ru) * 2020-08-05 2021-02-01 Федеральное государственное бюджетное образовательное учреждение высшего образования "Амурская государственная медицинская академия" Министерства здравоохранения Российской Федерации Способ коррекции антиоксидантного статуса при лечении больных эритематозно-телеангиэктатической и папуло-пустулезной формами розацеа легкой и средней степени тяжести

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1393221A (zh) * 2001-06-22 2003-01-29 姜涛 一种治疗痤疮的药液
US7060729B2 (en) * 2002-09-05 2006-06-13 Reza Babapour Composition and method for treating skin
DK1633374T3 (da) * 2003-06-10 2007-12-03 Intendis Gmbh Sammensætning af alkandicarboxylsyrer og et farmaceutisk aktivt stof
US20050026982A1 (en) * 2003-06-10 2005-02-03 Soenke Johannsen Composition that consists of alkanedicarboxylic acids and a pharmaceutical active ingredient

Also Published As

Publication number Publication date
JP2008513420A (ja) 2008-05-01
US20070219263A1 (en) 2007-09-20
CA2578121A1 (fr) 2006-03-30
FR2875404A1 (fr) 2006-03-24
EP1791598A1 (fr) 2007-06-06
WO2006032759A1 (fr) 2006-03-30

Similar Documents

Publication Publication Date Title
FR15C0046I2 (fr) Medicaments pour le traitement ou la prevention de maladies fibrotiques
FR2925339B1 (fr) Medicament pour le traitement du cancer du pancreas
DE602005007717D1 (de) Imidazolverbindungen zur behandlung von neurodegenerativen erkrankungen
FR13C0029I2 (fr) Compositions pour le traitement de troubles gastro-intestinaux
FR2851470B1 (fr) Composition pharmaceutique pour administration transdermique ou transmuqueuse
FR2902324B1 (fr) Utilisation d'acide ellagique pour le traitement de la canitie
CL2007002920A1 (es) Compuestos derivados de 2-aminocarbonilpiridina; composicion farmaceutica; y uso para el tratamiento de trastornos vasculares oclusivos.
FR2907011B1 (fr) Utilisation de la citrulline pour le traitement des etats de denutrition
NL1028599A1 (nl) Verbindingen voor de behandeling van ziekten.
FR2886851B1 (fr) Composition a base d'une avermectine et de metronidazole notamment pour le traitement de la rosacee
FR18C1008I2 (fr) Regime posologique de cladribine pour le traitement de la sclerose en plaques
ATE482709T1 (de) Neue arzneimittelkombinationen zur behandlung von atemwegserkrankungen
MA29097B1 (fr) Composes pour le traitement des infections virales par flaviviridae
CL2007003038A1 (es) Compuestos derivados de 2-fenil-6-aminocarbonil-pirimidina; composicion farmaceutica; y uso en el tratamiento de trastornos vasculares oclusivos.
ITRM20050179A1 (it) Composizione impiegabile per il trattamento delle patologie paradontali.
FR2896422B1 (fr) Systeme de drainage pour le traitement de l'hydrocephalie
ATE397937T1 (de) Medikament zur behandlung von pilzinfektionen; insbesondere aspergillose
FR2860154B1 (fr) Composition pour le traitement de la mauvaise haleine
FR2906468B1 (fr) Utilisation de composes de la famille des avermectines pour le traitement de desordres dermatologiques
DE602006013009D1 (de) Pharmazeutische zusammensetzung von mahanin zur behandlung von prostatakrebs
FR2886852B1 (fr) Composition a base d'une avermectine et d'hydrocortisone notamment pour le traitement de la rosacee
FR2875404B1 (fr) Composition pharmaceutique pour le traitement de la rosacee
FR2887785B1 (fr) Dispositif pour le traitement de substances organiques
FR2901703B1 (fr) Utilisation de zatosetron pour le traitement de la rosacee, et compositions pharmaceutiques
DE602004010172D1 (de) Pharmazeutische zusammensetzungen zur behandlung von nierenfunktionsstörungen

Legal Events

Date Code Title Description
CA Change of address
ST Notification of lapse

Effective date: 20100531